Fact CheckerSign in

NCT06534242Completed

Implication of Genetic Variations in Long Intergenic Non-coding RNA 00511 (LINC00511) in Colorectal Cancer

Source: ClinicalTrials.gov · Last updated 2 Aug 2024

Brief summary (registry, in English)

As, there is a lack of information about the association between LINC00511 SNP(s) variants and CRC susceptibility, so this study was undertaken to address whether these SNPs would increase CRC risk or could predict its prognosis. The aim of this study was to investigate the association between LINC00511 SNPs (rs17780195 or rs9906859 and rs1558535) and CRC susceptibility and/or pathogenesis in addition to finding out the interaction between these SNPs and clinicopathological factors such as histopathological type, tumor size, lymph node metastasis and tumor grade.

Status (registry)
Completed
Study type
Observational
Enrollment
400 (actual)
First submitted
30 Jul 2024
Start date
20 Jan 2022
Primary completion date
15 Feb 2023
Lead sponsor
Ain Shams University
NCT number
NCT06534242

What you commit to

  • Study type: Observational
  • Participants enrolled: 400
  • From 20 Jan 2022 to the primary completion date, 15 Feb 2023
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Subjects receiving any chemotherapy or radiotherapy, or had undergone a GIT surgical operation, patients with blood disorder diseases, any cancer other than CRC, patients with neuronal diseases, respiratory diseases, uterine diseases, kidney diseases, cirrhosis of the liver, prolonged use of corticosteroids or sex hormones.

Other illness

  • Patients with HBV, schistosomiasis, HIV, alcohol intake, thyroid dysfunction, inflammatory diseases, diabetes mellitus, and cardiovascular disorders.

Who the study is looking for

  • Adult and confirmed pathological examination of newly diagnosed CRC of no specific type.

Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Faculty of pharmacy, Ain Shams University, Advanced Biochemisrty Research Lab
Coordinator of this site? Confirm its status
CairoEgyptUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.